[The effect of ladasten on the activation-induced expression of Fas receptor on T-lymphocytes and their sensitivity to Fas-induced apoptosis].
Vakhitova IuV, Salimgareeva MKh, Sibiriak SV, Kurchatova NN, Seredin SB · 2004 · Eksperimental'naia i klinicheskaia farmakologiia; 2004 Sep-Oct
Study findings
In human peripheral-blood T cells, Ladasten increased selected activation-related responses and reduced Fas-induced apoptosis, while largely leaving activation-induced Fas expression unchanged.
- Population and setting
- Human T-cell preparations
- Evidence type
- In vitro
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Original full text and detailed methods have not been reviewed.
- Experimental findings do not establish human efficacy, dosing or long-term safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Vakhitova IuV, Salimgareeva MKh, Sibiriak SV, Kurchatova NN, Seredin SB. [The effect of ladasten on the activation-induced expression of Fas receptor on T-lymphocytes and their sensitivity to Fas-induced apoptosis]. Eksperimental'naia i klinicheskaia farmakologiia; 2004 Sep-Oct 2004.
Molekul research summary: https://molekul.io/research/brom-extra-15559634. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry